Clinical Trial Update: An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE) [Phase 2]

View source ↗

Summary

An open-label extension study (FREEDOM-OLE) of the investigational drug PGN-EDODM1 in people with Myotonic Dystrophy Type 1, a Phase 2 trial that is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• PGN-EDODM1

Snippet

Sponsor: PepGen Inc | Conditions: Myotonic Dystrophy 1 | Phase 2 | Status: RECRUITING